Nanoparticulate systems for brain delivery of drugs (Q33938252)

30 July 2017

1 reference

title

Nanoparticulate systems for brain delivery of drugs (English)

1 reference

30 July 2017

1 reference

Kreuter J

1

1 reference

PubMed ID

11251246

30 July 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

Advanced Drug Delivery Reviews

30 July 2017

1 reference

30 July 2017

47

1 reference

30 July 2017

1

1 reference

30 July 2017

65-81

1 reference

The blood-brain barrier: principles for targeting peptides and drugs to the central nervous system

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Biodistribution of calcitonin encapsulated in liposomes in mice with particular reference to the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Brain drug delivery of small molecules using immunoliposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Modulation of blood-brain barrier permeability

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injections.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Circadian phase-dependent antinociceptive reaction in mice determined by the hot-plate test and the tail-flick test after intravenous injection of dalargin-loaded nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Nanoparticle technology for delivery of drugs across the blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Efficacy of oral dalargin-loaded nanoparticle delivery across the blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Genetic differences in daily rhythms of pain sensitivity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Hyperalgesia Induced by Naloxone Follows Diurnal Rhythm in Responsivity to Painful Stimuli

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Body distribution of 3H-labelled dalargin bound to poly(butyl cyanoacrylate) nanoparticles after i.v. injections to mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Increase of the duration of the anticonvulsive activity of a novel NMDA receptor antagonist using poly(butylcyanoacrylate) nanoparticles as a parenteral controlled release system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Effect of the nonionic surfactant poloxamer 338 on the fate and deposition of polystyrene microspheres following intravenous administration

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer--poloxamine 908

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Toxicity of polyalkylcyanoacrylate nanoparticles II: Doxorubicin-loaded nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Enhanced brain tumor selectivity of cationic magnetic polysaccharide microspheres.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Interaction of poly(butylcyanoacrylate) nanoparticles with the blood-brain barrier in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

An easier, reproducible, and mass-production method to study the blood-brain barrier in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Drug transfer across the blood-brain barrier: correlation between in vitro and in vivo models

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Brain distribution spaces of mannitol-3H, inulin-14C, and dextran-14C in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Spinal subarachnoid perfusion of rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Regional brain blood flow, blood volume, and haematocrit values in the adult rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Structural and Functional Variations in Capillary Systems within the Brain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Low-density lipoprotein receptor on endothelium of brain capillaries

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Characterization of the scavenger receptor on bovine cerebral endothelial cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Upregulation of the low density lipoprotein receptor at the blood-brain barrier: intercommunications between brain capillary endothelial cells and astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Expression of receptors for native and chemically modified low-density lipoproteins in brain microvessels

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Reversal of multidrug resistance by surfactants

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900122-8

7 January 2021

10.1016/S0169-409X(00)00122-8

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

11251246